About the Global Psychedelic Dinners
Host a Global Psychedelic Dinner to Help Make Psychedelic Therapy a Legal Treatment
By hosting your own Global Psychedelic Dinner, you'll join people around the world in gathering your community, hosting an open conversation about psychedelic science and medicine, spreading the word, and raising funds for MAPS’ purchase of one kilogram of pharmaceutical grade MDMA for our Phase 3 trials of MDMA-assisted psychotherapy for posttraumatic stress disorder (PTSD).
In addition to raising funds for vital research, the Global Psychedelic Dinners are also your chance to share your story about why you support psychedelic science and medicine. You'll be helping reduce stigma and enhance public understanding of the risks and beneficial uses of psychedelics for science, healing, spirituality, creativity, and personal growth. Come out of the psychedelic closet and help integrate psychedelics back into mainstream culture.
Everyone who hosts or attends the dinners can easily create their own online fundraising page so they can ask their friends, family, and colleagues to sponsor their participation and help make MDMA a legal medicine.
What is MAPS?
Founded in 1986, the Multidisciplinary Association for Psychedelic Studies (MAPS) is a 501(c)(3) non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana.
Since 1986, MAPS has disbursed over $26 million to scientific research and public education about the risks and benefits of psychedelics and marijuana. Almost all our support comes from individuals and family foundations.
MAPS has completed an international series of Phase 2 clinical trials of MDMA-assisted psychotherapy for PTSD, and is now preparing for the much larger Phase 3 trials required to obtain U.S. Food and Drug Administration (FDA) approval, starting in 2017. As long as we receive the necessary funding, we anticipate FDA approval for MDMA-assisted psychotherapy for PTSD as soon as 2021.
MAPS works to develop psychedelics and marijuana into prescription medicines
MAPS sponsors scientific research into the treatment of specific conditions, while also supporting scientific research into spirituality, creativity, and neuroscience.
MAPS works to educate the public honestly about the risks and benefits of psychedelics and marijuana.
MAPS works to train therapists and to establish a network of treatment centers.
Learn more at maps.org.
in partnership with: